Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of bosentan for digital ulcers related to systemic sclerosis: a real-life retrospective French study of 89 patients treated since specific approval.
Agard C, Carpentier PH, Mouthon L, Clerson P, Gressin V, Bérezné A, Diot E, Jego P, Lok C, Sparsa A, Chatelus E, Van Kien AK, Quéré I, Sibilia J, Hachulla E. Agard C, et al. Among authors: sparsa a. Scand J Rheumatol. 2014;43(5):398-402. doi: 10.3109/03009742.2014.887768. Epub 2014 Apr 11. Scand J Rheumatol. 2014. PMID: 24720440
Ischemic digital ulcers affect hand disability and pain in systemic sclerosis.
Mouthon L, Carpentier PH, Lok C, Clerson P, Gressin V, Hachulla E, Bérezné A, Diot E, Khau Van Kien A, Jego P, Agard C, Duval-Modeste AB, Sparsa A, Puzenat E, Richard MA; ECLIPSE Study Investigators. Mouthon L, et al. Among authors: sparsa a. J Rheumatol. 2014 Jul;41(7):1317-23. doi: 10.3899/jrheum.130900. Epub 2014 Jun 15. J Rheumatol. 2014. PMID: 24931950
Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function.
Mouthon L, Carpentier PH, Lok C, Clerson P, Gressin V, Hachulla E, Bérezné A, Diot E, Van Kien AK, Jego P, Agard C, Duval-Modeste AB, Sparsa A, Puzenat E, Richard MA; ECLIPSE study investigators. Mouthon L, et al. Among authors: sparsa a. Semin Arthritis Rheum. 2017 Jun;46(6):759-766. doi: 10.1016/j.semarthrit.2017.01.001. Epub 2017 Jan 13. Semin Arthritis Rheum. 2017. PMID: 28214014
Characteristics, prognosis, and outcomes of cutaneous ischemia and gangrene in systemic necrotizing vasculitides: a retrospective multicenter study.
Lega JC, Seror R, Fassier T, Aumaître O, Quere I, Pourrat J, Gilson B, Sparsa A, Wahl D, Le Jeunne C, Decaux O, Mouthon L, Mahr A, Cohen P, Guillevin L, Pagnoux C; French Vasculitis Study Group (FVSG). Lega JC, et al. Among authors: sparsa a. Semin Arthritis Rheum. 2014 Apr;43(5):681-8. doi: 10.1016/j.semarthrit.2013.09.001. Epub 2013 Oct 9. Semin Arthritis Rheum. 2014. PMID: 24120178
Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial.
Prey S, Ezzedine K, Doussau A, Grandoulier AS, Barcat D, Chatelus E, Diot E, Durant C, Hachulla E, de Korwin-Krokowski JD, Kostrzewa E, Quemeneur T, Paul C, Schaeverbeke T, Seneschal J, Solanilla A, Sparsa A, Bouchet S, Lepreux S, Mahon FX, Chene G, Taïeb A. Prey S, et al. Among authors: sparsa a. Br J Dermatol. 2012 Nov;167(5):1138-44. doi: 10.1111/j.1365-2133.2012.11186.x. Epub 2012 Oct 5. Br J Dermatol. 2012. PMID: 23039171 Clinical Trial.
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.
Kleinmann JF, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacre K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, Cacoub P, Caillard S, Chiche L, Chosidow O, Costedoat-Chalumeau N, Daien C, Daugas E, Derdèche N, Doria A, Fain O, Fakhouri F, Farge D, Gabay C, Guillo S, Hachulla E, Hajjaj-Hassouni N, Hamidou M, Houssiau FA, Jourde-Chiche N, Koné-Paut I, Ladjouz-Rezig A, Lambotte O, Lipsker D, Mariette X, Martin-Silva N, Martin T, Maurier F, Meckenstock R, Mékinian A, Meyer O, Mohamed S, Morel J, Moulin B, Mulleman D, Papo T, Poindron V, Puéchal X, Punzi L, Quartier P, Sailler L, Smail A, Soubrier M, Sparsa A, Tazi-Mezalek Z, Zakraoui L, Zuily S, Sibilia J, Gottenberg JE. Kleinmann JF, et al. Among authors: sparsa a. Autoimmun Rev. 2017 Jun;16(6):650-657. doi: 10.1016/j.autrev.2017.04.011. Epub 2017 Apr 18. Autoimmun Rev. 2017. PMID: 28434948
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study.
Joly P, Roujeau JC, Benichou J, Delaporte E, D'Incan M, Dreno B, Bedane C, Sparsa A, Gorin I, Picard C, Tancrede-Bohin E, Sassolas B, Lok C, Guillaume JC, Doutre MS, Richard MA, Caux F, Prost C, Plantin P, Chosidow O, Pauwels C, Maillard H, Saiag P, Descamps V, Chevrant-Breton J, Dereure O, Hellot MF, Esteve E, Bernard P. Joly P, et al. Among authors: sparsa a. J Invest Dermatol. 2009 Jul;129(7):1681-7. doi: 10.1038/jid.2008.412. Epub 2009 Jan 29. J Invest Dermatol. 2009. PMID: 19177141 Free article. Clinical Trial.
Aortic angiosarcoma clinically mimicking polyarteritis nodosa.
Sparsa A, Liozon E, Wechsler J, Soria P, Delage-Core M, Loustaud V, Bedane C, Bonnetblanc JM, Vidal E. Sparsa A, et al. Scand J Rheumatol. 2006 May-Jun;35(3):237-40. doi: 10.1080/03009740500484031. Scand J Rheumatol. 2006. PMID: 16766373
Anetoderma and its prothrombotic abnormalities.
Sparsa A, Piette JC, Wechsler B, Amoura Z, Francès C. Sparsa A, et al. J Am Acad Dermatol. 2003 Dec;49(6):1008-12. doi: 10.1016/s0190-9622(03)02110-8. J Am Acad Dermatol. 2003. PMID: 14639377
Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.
Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, Bedane C, Delaporte E, Roujeau JC, Bernard P, Guillaume JC, Ingen-Housz-Oro S, Maillard H, Pauwels C, Picard-Dahan C, Dutronc Y, Richard MA; French Study Group for Bullous Diseases. Bastuji-Garin S, et al. Among authors: sparsa a. J Invest Dermatol. 2011 Mar;131(3):637-43. doi: 10.1038/jid.2010.301. Epub 2010 Oct 14. J Invest Dermatol. 2011. PMID: 20944650 Free article.
80 results